Cyclophilin A‐mediated mitigation of coronavirus SARS‐CoV‐2

Cyclophilin A‐mediated mitigation of coronavirus SARS‐CoV‐2

Abstract Human cyclophilin A (hCypA) is important for the replication of multiple coronaviruses (CoVs), and cyclosporine A inhibitors can suppress CoVs. The emergence of rapidly spreading severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variants has sparked concerns that mutations affect...

Full description

Bibliographic Details
Main Authors: Simranjeet Singh Sekhon, Woo‐Ri Shin, Sang Yong Kim, Dong‐Seok Jeong, Wooil Choi, Bong‐Keun Choi, Jiho Min, Ji‐Young Ahn, Yang‐Hoon Kim
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Bioengineering & Translational Medicine
Subjects:
cyclophilin
COVID‐19 variants
coronavirus
spike protein receptor‐binding domain
surface plasmon resonance
Online Access:https://doi.org/10.1002/btm2.10436

Internet

https://doi.org/10.1002/btm2.10436

Similar Items